Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Stability of ramipril in the solvents of different pH

Hanysová L, Václavková M, Dohnal J, Klimes J.

. 2005 ; 37 (5) : 1179-1183.

Jazyk angličtina Země Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc07520441

The stability of ramipril in the buffer solution with different pH and the influence of acid, alkaline and oxidative medium on ramipril stability were studied. The ramipril degradation products were determined by high-performance liquid chromatography (HPLC) method. Acetonitrile:sodium perchlorate was used as the mobile phase, at a flow rate of 1.0 ml/min (linear gradient elution). A Nucleosil 100-S 5 microm C18, 250 mm x 4.6 mm i.d. was utilized as stationary phase. Detection was affected spectrophotometrically at 210 nm. The drug substance was dissolved in the ammonium phosphate buffer (pH 3, 5 and 8) and these solutions were stored at 90 degrees C for 1 h. The other series of test solutions were prepared from stock solution (drug substance dissolved in solvent A of the mobile phase) by dilution in acid (0.1M HCl), alkaline (0.1M NaOH) and oxidative (hydrogen peroxide solution) medium. More then 0.2% of impurity D (ramipril-diketopiperazine) was detected in the buffer of pH 3 and pH 5. In the buffer of pH 8 there was detected more then 1% of impurity E (ramipril-diacid). No peaks for degradation products appeared in the chromatograms above limit of quantification. The alkaline medium has the greatest effect on degradation of ramipril into impurity E (more than 50%).

Citace poskytuje Crossref.org

000      
00000naa 2200000 a 4500
001      
bmc07520441
003      
CZ-PrNML
005      
20111210131126.0
008      
090402s2005 xxk e eng||
009      
AR
024    __
$a 10.1016/j.jpba.2004.10.041 $2 doi
035    __
$a (PubMed)15862704
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Hanyšová, L.
245    10
$a Stability of ramipril in the solvents of different pH / $c Hanysová L, Václavková M, Dohnal J, Klimes J.
314    __
$a Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. polasek@faf.cuni.cz
520    9_
$a The stability of ramipril in the buffer solution with different pH and the influence of acid, alkaline and oxidative medium on ramipril stability were studied. The ramipril degradation products were determined by high-performance liquid chromatography (HPLC) method. Acetonitrile:sodium perchlorate was used as the mobile phase, at a flow rate of 1.0 ml/min (linear gradient elution). A Nucleosil 100-S 5 microm C18, 250 mm x 4.6 mm i.d. was utilized as stationary phase. Detection was affected spectrophotometrically at 210 nm. The drug substance was dissolved in the ammonium phosphate buffer (pH 3, 5 and 8) and these solutions were stored at 90 degrees C for 1 h. The other series of test solutions were prepared from stock solution (drug substance dissolved in solvent A of the mobile phase) by dilution in acid (0.1M HCl), alkaline (0.1M NaOH) and oxidative (hydrogen peroxide solution) medium. More then 0.2% of impurity D (ramipril-diketopiperazine) was detected in the buffer of pH 3 and pH 5. In the buffer of pH 8 there was detected more then 1% of impurity E (ramipril-diacid). No peaks for degradation products appeared in the chromatograms above limit of quantification. The alkaline medium has the greatest effect on degradation of ramipril into impurity E (more than 50%).
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a stabilita léku $7 D004355
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a ramipril $x analýza $x chemie $7 D017257
650    _2
$a rozpouštědla $x analýza $x chemie $7 D012997
700    1_
$a Václavková, M.
700    1_
$a Dohnal, J.
700    1_
$a Klimeš, Jiří, $d 1950- $7 jn20000710203
773    0_
$w MED00002894 $t Journal of pharmaceutical and biomedical analysis $g Roč. 37, č. 5 (2005), s. 1179-1183 $x 0731-7085
910    __
$a ABA008 $b x $y 9
990    __
$a 20090310084605 $b ABA008
991    __
$a 20090621161710 $b ABA008
999    __
$a ok $b bmc $g 638244 $s 491043
BAS    __
$a 3
BMC    __
$a 2005 $b 37 $c 5 $d 1179-1183 $i 0731-7085 $m Journal of pharmaceutical and biomedical analysis $x MED00002894
LZP    __
$a 2009-B2/ipme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...